Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for Grade 3-4 and Refractory Acute GVHD
NCT04448587Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Start
- Oct 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitagliptin in Acute Graft-Versus-Host Disease (aGVHD), sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
sitagliptin
03
Conditions
Acute Graft-Versus-Host Disease (aGVHD)
Beyond the preview
Go deeper on NCT04448587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04448587.